These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 11507037)

  • 21. Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.
    Santin AD; Zhan F; Bignotti E; Siegel ER; Cané S; Bellone S; Palmieri M; Anfossi S; Thomas M; Burnett A; Kay HH; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
    Virology; 2005 Jan; 331(2):269-91. PubMed ID: 15629771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma.
    Shah US; Dhir R; Gollin SM; Chandran UR; Lewis D; Acquafondata M; Pflug BR
    Hum Pathol; 2006 Apr; 37(4):401-9. PubMed ID: 16564913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
    Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
    Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of ezrin in prostatic intraepithelial neoplasia.
    Pang ST; Fang X; Valdman A; Norstedt G; Pousette A; Egevad L; Ekman P
    Urology; 2004 Mar; 63(3):609-12. PubMed ID: 15028477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
    Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.
    Hofmann HS; Bartling B; Simm A; Murray R; Aziz N; Hansen G; Silber RE; Burdach S
    Oncol Rep; 2006 Sep; 16(3):587-95. PubMed ID: 16865260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
    Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
    Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis.
    Rasiah KK; Kench JG; Gardiner-Garden M; Biankin AV; Golovsky D; Brenner PC; Kooner R; O'neill GF; Turner JJ; Delprado W; Lee CS; Brown DA; Breit SN; Grygiel JJ; Horvath LG; Stricker PD; Sutherland RL; Henshall SM
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):711-6. PubMed ID: 16614113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telomerase expression as a marker in prostate cancer: correlation to clinicopathologic predictors.
    Athanassiadou P; Bantis A; Gonidi M; Liossi A; Aggelonidou E; Petrakakou E; Giannopoulos A
    J Exp Clin Cancer Res; 2003 Dec; 22(4):613-8. PubMed ID: 15053304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15.
    Huang CY; Beer TM; Higano CS; True LD; Vessella R; Lange PH; Garzotto M; Nelson PS
    Clin Cancer Res; 2007 Oct; 13(19):5825-33. PubMed ID: 17908975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples.
    Festuccia C; Angelucci A; Gravina GL; Muzi P; Miano R; Vicentini C; Bologna M
    Int J Oncol; 2005 May; 26(5):1353-62. PubMed ID: 15809728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism.
    Tamura K; Makino A; Hullin-Matsuda F; Kobayashi T; Furihata M; Chung S; Ashida S; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
    Cancer Res; 2009 Oct; 69(20):8133-40. PubMed ID: 19826053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High expression of a new marker PCA-1 in human prostate carcinoma.
    Konishi N; Nakamura M; Ishida E; Shimada K; Mitsui E; Yoshikawa R; Yamamoto H; Tsujikawa K
    Clin Cancer Res; 2005 Jul; 11(14):5090-7. PubMed ID: 16033822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genes differentially expressed in prostate cancer.
    Eder IE; Bektic J; Haag P; Bartsch G; Klocker H
    BJU Int; 2004 May; 93(8):1151-5. PubMed ID: 15142130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of genes potentially involved in the acquisition of androgen-independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer model.
    Morgenbesser SD; McLaren RP; Richards B; Zhang M; Akmaev VR; Winter SF; Mineva ND; Kaplan-Lefko PJ; Foster BA; Cook BP; Dufault MR; Cao X; Wang CJ; Teicher BA; Klinger KW; Greenberg NM; Madden SL
    Prostate; 2007 Jan; 67(1):83-106. PubMed ID: 17013881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.
    Gnanapragasam VJ; Leung HY; Pulimood AS; Neal DE; Robson CN
    Br J Cancer; 2001 Dec; 85(12):1928-36. PubMed ID: 11747336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence.
    Seligson DB; Hongo F; Huerta-Yepez S; Mizutani Y; Miki T; Yu H; Horvath S; Chia D; Goodglick L; Bonavida B
    Clin Cancer Res; 2007 Oct; 13(20):6056-63. PubMed ID: 17947468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen.
    Ghadersohi A; Sood AK
    Clin Cancer Res; 2001 Sep; 7(9):2731-8. PubMed ID: 11555586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrative biology of prostate cancer progression.
    Tomlins SA; Rubin MA; Chinnaiyan AM
    Annu Rev Pathol; 2006; 1():243-71. PubMed ID: 18039115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of neuregulin 4 splice variants in normal human tissues and prostate cancer and their effects on cell motility.
    Hayes NV; Blackburn E; Boyle MM; Russell GA; Frost TM; Morgan BJ; Gullick WJ
    Endocr Relat Cancer; 2011 Feb; 18(1):39-49. PubMed ID: 20959441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.